Globus Medical A Stock Current Valuation
| GM0N Stock | EUR 78.00 2.00 2.50% |
Valuation analysis of GLOBUS MEDICAL A helps investors to measure GLOBUS MEDICAL's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that GLOBUS MEDICAL's price fluctuation is very steady at this time. Calculation of the real value of GLOBUS MEDICAL A is based on 3 months time horizon. Increasing GLOBUS MEDICAL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GLOBUS stock is determined by what a typical buyer is willing to pay for full or partial control of GLOBUS MEDICAL A. Since GLOBUS MEDICAL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GLOBUS Stock. However, GLOBUS MEDICAL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 78.0 | Real 75.0 | Hype 78.0 | Naive 79.2 |
The real value of GLOBUS Stock, also known as its intrinsic value, is the underlying worth of GLOBUS MEDICAL A Company, which is reflected in its stock price. It is based on GLOBUS MEDICAL's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GLOBUS MEDICAL's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GLOBUS MEDICAL A helps investors to forecast how GLOBUS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GLOBUS MEDICAL more accurately as focusing exclusively on GLOBUS MEDICAL's fundamentals will not take into account other important factors: GLOBUS MEDICAL A Company Current Valuation Analysis
GLOBUS MEDICAL's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GLOBUS MEDICAL Current Valuation | 6.66 B |
Most of GLOBUS MEDICAL's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GLOBUS MEDICAL A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GLOBUS MEDICAL A has a Current Valuation of 6.66 B. This is much higher than that of the sector and significantly higher than that of the Other industry. The current valuation for all Germany stocks is notably lower than that of the firm.
GLOBUS Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GLOBUS MEDICAL's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GLOBUS MEDICAL could also be used in its relative valuation, which is a method of valuing GLOBUS MEDICAL by comparing valuation metrics of similar companies.GLOBUS MEDICAL is currently under evaluation in current valuation category among its peers.
GLOBUS Fundamentals
| Current Valuation | 6.66 B | |||
| Price To Book | 4.15 X | |||
| Price To Sales | 7.57 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 304.5 M | |||
| Net Income | 190.17 M | |||
| Cash Flow From Operations | 178.47 M | |||
| Price To Earnings To Growth | 2.80 X | |||
| Number Of Employees | 12 | |||
| Market Capitalization | 6.1 B | |||
| Total Asset | 2.08 B | |||
| Net Asset | 2.08 B |
About GLOBUS MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GLOBUS MEDICAL A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GLOBUS MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GLOBUS MEDICAL A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.